San Francisco Sentry Investment Group’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $1.68M | Hold |
48,000
| – | – | 0.88% | 17 |
|
|
2021
Q1 | $4.73M | Hold |
48,000
| – | – | 2.02% | 6 |
|
|
2020
Q4 | $5.2M | Hold |
48,000
| – | – | 2.45% | 4 |
|
|
2020
Q3 | $4.94M | Hold |
48,000
| – | – | 2.54% | 4 |
|
|
2020
Q2 | $10M | Hold |
48,000
| – | – | 5.33% | 2 |
|
|
2020
Q1 | $4.69M | Hold |
48,000
| – | – | 2.97% | 5 |
|
|
2019
Q4 | $5.53M | Hold |
48,000
| – | – | 2.48% | 4 |
|
|
2019
Q3 | $2.62M | Hold |
48,000
| – | – | 1.2% | 18 |
|
|
2019
Q2 | $5.71M | Hold |
48,000
| – | – | 2.62% | 3 |
|
|
2019
Q1 | $2.52M | Hold |
48,000
| – | – | 1.09% | 14 |
|
|
2018
Q4 | $1.51M | Hold |
48,000
| – | – | 0.71% | 25 |
|
|
2018
Q3 | $2.9M | Hold |
48,000
| – | – | 1.09% | 14 |
|
|
2018
Q2 | $2.54M | Hold |
48,000
| – | – | 1.06% | 16 |
|
|
2018
Q1 | $2.78M | Hold |
48,000
| – | – | 0.8% | 21 |
|
|
2017
Q4 | $1.68M | Buy |
+48,000
| New | +$1.68M | 0.49% | 40 |
|